Your browser doesn't support javascript.
loading
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection.
Lee, Wen Shi; Tan, Hyon-Xhi; Reynaldi, Arnold; Esterbauer, Robyn; Koutsakos, Marios; Nguyen, Julie; Amarasena, Thakshila; Kent, Helen E; Aggarwal, Anupriya; Turville, Stuart G; Taiaroa, George; Kinsella, Paul; Liew, Kwee Chin; Tran, Thomas; Williamson, Deborah A; Cromer, Deborah; Davenport, Miles P; Kent, Stephen J; Juno, Jennifer A; Khoury, David S; Wheatley, Adam K.
Affiliation
  • Lee WS; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Tan HX; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Reynaldi A; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
  • Esterbauer R; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Koutsakos M; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Nguyen J; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Amarasena T; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Kent HE; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Aggarwal A; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
  • Turville SG; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
  • Taiaroa G; Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Kinsella P; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Liew KC; Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Tran T; Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Williamson DA; Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Cromer D; Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Davenport MP; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Kent SJ; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
  • Juno JA; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
  • Khoury DS; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Wheatley AK; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia.
Sci Adv ; 9(29): eadg5301, 2023 07 21.
Article in En | MEDLINE | ID: mdl-37478181
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 / Breakthrough Infections Type of study: Prognostic_studies Limits: Humans Language: En Journal: Sci Adv Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 / Breakthrough Infections Type of study: Prognostic_studies Limits: Humans Language: En Journal: Sci Adv Year: 2023 Document type: Article Affiliation country: Country of publication: